omniture
logo
Search
上海药明康德新药开发有限公司 SHANGHAI PHARMATECHS CO.LTD
Media Room

Photo News

rss
WuXi Advanced Therapies Receives FDA Approval to Manufacture Iovance's AMTAGVI™ (lifileucel) for Advanced Melanoma

WuXi Advanced Therapies Receives FDA Approval to Manufacture Iovance's AMTAGVI™ (lifileucel) for Advanced Melanoma

2024-02-20 21:00 3348
WuXi AppTec Triples Peptide Manufacturing Capacity and Launches the New Taixing API Manufacturing Site

WuXi AppTec Triples Peptide Manufacturing Capacity and Launches the New Taixing API Manufacturing Site

2024-01-08 22:00 5074
WuXi STA Opens First High Potency Oral Drug Product Manufacturing Facility

WuXi STA Opens First High Potency Oral Drug Product Manufacturing Facility

2022-09-26 20:00 1652
WuXi STA Opens a New Sterile Lipid Nanoparticle Formulation Facility to Enhance Global CRDMO Services for Customers

WuXi STA Opens a New Sterile Lipid Nanoparticle Formulation Facility to Enhance Global CRDMO Services for Customers

2022-09-09 20:00 1801
WuXi STA Breaks Ground for New Pharmaceutical Manufacturing Facility in Middletown, Delaware

WuXi STA Breaks Ground for New Pharmaceutical Manufacturing Facility in Middletown, Delaware

2022-08-17 01:47 4494
WuXi STA Opens New Large-scale Oligonucleotide and Peptide Manufacturing Facility

WuXi STA Opens New Large-scale Oligonucleotide and Peptide Manufacturing Facility

2022-07-07 08:00 3784
WuXi AppTec Recognized as Top-Rated ESG Company by Sustainalytics

WuXi AppTec Recognized as Top-Rated ESG Company by Sustainalytics

2022-04-08 08:00 1911
WuXi STA Wins 2022 CMO Leadership Awards in All Six Core Categories

WuXi STA Wins 2022 CMO Leadership Awards in All Six Core Categories

2022-02-11 10:00 1792
WuXi AppTec Receives AA ESG Rating from MSCI

WuXi AppTec Receives AA ESG Rating from MSCI

2021-09-06 08:00 2517